We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
TT
1701
Tiedemann Trust
Delaware
$378K -$72.1K -2,292 -16%
ACM
1702
Apex Capital Management
Ohio
$377K -$3.23M -102,757 -89%
GIP
1703
Granite Investment Partners
California
$376K -$3.08K -98 -0.8%
Manulife (Manufacturers Life Insurance)
1704
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$374K -$38.4M -1,219,996 -9%
LBG
1705
Lloyds Banking Group
United Kingdom
$374K -$197K -6,252 -34%
NPF
1706
Norris Perne & French
Michigan
$374K
CPIG
1707
Chicago Partners Investment Group
Illinois
$371K +$131K +4,163 +52%
VFP
1708
Verus Financial Partners
Virginia
$368K -$6.01K -191 -2%
CAL
1709
Capital Advisors Ltd
Ohio
$365K -$8.93K -284 -2%
PAS
1710
Partnervest Advisory Services
California
$365K +$9.53K +303 +3%
BMM
1711
Buffington Mohr McNeal
Idaho
$365K +$374K +11,904 New
MBI
1712
Montrusco Bolton Investments
Quebec, Canada
$361K +$370K +11,773 New
BKA
1713
Brick & Kyle Associates
Pennsylvania
$359K +$6.86K +218 +2%
USGIU
1714
U.S. Global Investors (USGI)
Texas
$355K +$149K +4,743 +69%
CB
1715
Cooke & Bieler
Pennsylvania
$352K -$25.5K -811 -7%
AWM
1716
AllSquare Wealth Management
New York
$352K +$99.5K +3,162 +38%
SWK
1717
Stephen W. Kidder
$351K
IC
1718
InterOcean Capital
Illinois
$350K -$849 -27 -0.2%
HCM
1719
Highlander Capital Management
New Jersey
$348K -$66.3K -2,109 -16%
PMAM
1720
Picton Mahoney Asset Management
Ontario, Canada
$346K
HHGA
1721
Halbert Hargrove Global Advisors
California
$345K -$13.2K -419 -4%
PFM
1722
Parsec Financial Management
North Carolina
$345K +$31.9K +1,013 +10%
DLHL
1723
Donald L. Hagan LLC
Florida
$341K
NG
1724
Northstar Group
New York
$341K +$1.04K +33 +0.3%
DAC
1725
Dividend Assets Capital
South Carolina
$340K -$6.1K -194 -2%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.